American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 04-2001 | 03-2001 | 01-2001 | 12-2000 | 10-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -465 | -1,389 | -860 | -867 |
| Depreciation Amortization | N/A | 32 | 548 | 420 | 61 |
| Accounts receivable | N/A | 379 | 102 | N/A | -447 |
| Accounts payable and accrued liabilities | N/A | -235 | 31 | N/A | 295 |
| Other Working Capital | N/A | 477 | 40 | -210 | -211 |
| Other Operating Activity | 0 | -151 | -183 | -40 | 612 |
| Operating Cash Flow | $N/A | $37 | $-851 | $-690 | $-557 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -11 | -59 | -40 | -40 |
| Sale Of Investment | N/A | -2 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 160 | -220 | -220 |
| Investing Cash Flow | $N/A | $-13 | $101 | $-260 | $-260 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -125 | N/A | N/A |
| Debt Repayment | N/A | -2 | -7 | N/A | -6 |
| Other Financing Activity | 0 | 0 | 0 | -130 | -125 |
| Financing Cash Flow | $N/A | $-2 | $-132 | $-130 | $-131 |
| Beginning Cash Position | N/A | 91 | 1,207 | 1,200 | 1,207 |
| End Cash Position | N/A | 113 | 325 | 250 | 259 |
| Net Cash Flow | $N/A | $22 | $-882 | $-940 | $-948 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 37 | -851 | -690 | -557 |
| Capital Expenditure | N/A | -11 | -59 | N/A | -40 |
| Free Cash Flow | 0 | 26 | -910 | -690 | -597 |